FLNA · Filana Therapeutics, Inc. · Executive Compensation
Market Cap
$33.26M
Shares
48.31M
Volume · Oct 20
198.36K
Avg daily vol (3M)
2M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Richard J. Barry | President and Chief Executive Officer | $1,520,035 |
| Eric J. Schoen | Chief Financial Officer | $830,010 |
| R. Christopher Cook | Chief Operating and Legal Officer | $818,985 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Richard J. Barry | President and Chief Executive Officer | $16,729,425 |
| Eric J. Schoen | Chief Financial Officer | $3,850,772 |
| Remi Barbier | Former President and Chief Executive Officer | $3,685,803 |
| James W. Kupiec | Chief Medical Officer | $3,306,128 |
| R. Christopher Cook | Chief Operating and Legal Officer | $3,295,128 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Remi Barbier | Former President and Chief Executive Officer | $6,263,038 |
| Eric J. Schoen | Chief Financial Officer | $2,992,825 |
| James W. Kupiec | Chief Medical Officer | $2,967,825 |
| R. Christopher Cook | Sr. VP and General Counsel | $1,269,275 |
| Richard J. Barry | President and Chief Executive Officer | $546,155 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| R. Christopher Cook | Sr. VP and General Counsel | $3,656,062 |
| Remi Barbier | President, Chief Executive Officer and Chairman of the Board | $1,114,998 |
| Nadav Friedmann | Ph.D., M.D. Chief Medical Officer and Director | $479,167 |
| Eric J. Schoen | Chief Financial Officer | $426,610 |
| James W. Kupiec | Chief Medical Officer | $400,000 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Remi Barbier | President, Chief Executive Officer and Chairman of the Board | $1,741,120 |
| Eric J. Schoen | Chief Financial Officer | $776,932 |
| Nadav Friedmann | Ph.D., M.D. Chief Medical Officer and Director | $765,000 |
| James W. Kupiec | Chief Medical Officer | $473,579 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Remi Barbier | President, Chief Executive Officer and Chairman of the Board | $936,120 |
| Nadav Friedmann | Ph.D., M.D. Chief Medical Officer and Director | $345,000 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Claude Nicaise, M.D. | Director | Appointed | 2026-06-15 |
| Pierre Gravier | Director | Appointed | 2026-06-15 |
| Richard J. Barry | Director | Appointed | 2026-06-15 |
| Michael O'Donnell | the Board | Resigned | 2026-04-28 |
| Dawn Carter Bir | Class I director | Appointed | 2025-10-22 |
| Michael J. O'Donnell | Director | Appointed | 2025-05-27 |
| Robert Anderson, Jr. | Director | Appointed | 2025-05-27 |
| Jack Moore | Senior Vice President, Clinical Development | Appointed | 2025-04-21 |
| James W. Kupiec | Chief Medical Officer | Retired | 2025-04-21 |
| R. Christopher Cook | Chief Operating and Legal Officer | Appointed | 2025-04-21 |
| James W. Kupiec, M.D. | Chief Medical Officer | Retired | 2025-04-21 |
| Claude Nicaise, M.D. | Chairman | Appointed | 2024-09-09 |
| Richard (Rick) Barry | Chief Executive Officer | Appointed | 2024-09-09 |
| Lindsay Burns | SVP, Neuroscience | Resigned | 2024-07-17 |
| Remi Barbier | board membership | Resigned | 2024-07-17 |
| Richard J. Barry | Executive Chairman | Appointed | 2024-07-17 |
| Remi Barbier | Chairman of the Board | Resigned | 2024-07-17 |
| Remi Barbier | President and Chief Executive Officer | Resigned | 2024-07-17 |
| Robert Anderson, Jr. | Class I director | Appointed | 2023-12-11 |
| Pierre Gravier | Class II director | Appointed | 2023-12-11 |
| Claude Nicaise | Class II director | Appointed | 2023-12-11 |
| R. Christopher Cook | Senior Vice President and General Counsel | Appointed | 2022-10-27 |
Leadership
- Richard (Rick) Barry CEO
- Richard J. Barry CEO, Chairman, Board Member
- Claude Nicaise Chairman
- Claude Nicaise, M.D. Chairman, Board Member
- Eric J. Schoen CFO
- R. Christopher Cook COO, General Counsel
- Dawn C. Bir Board Member
- Dawn Carter Bir Board Member
- Dr. Claude Nicaise Board Member
- Michael J. O'Donnell Board Member
- Patrick J. Scannon Board Member
- Pierre Gravier Board Member
- Robert Anderson Board Member
- Robert Anderson, Jr. Board Member
- Robert Z. Gussin Board Member